Having a modified exposure claim would greatly boost 22nd Century’s sales, says CEO. Read More
Tags : 22nd Century Group
Koganov is an expert in the development of natural products using biotechnology.Read More
The company's manufacturing facility has remained open and has been able to fulfill orders without any backlog. Read More
22nd Century Group and North Carolina State University have developed several new very-low-nicotine tobacco varieties that contain no foreign DNA and no trace of genetic modification.Read More
22nd Century Group, a plant biotechnology company and leader in tobacco harm reduction, has announced that it will open specialized laboratories in western New York, USA, dedicated to new scientific research at substantially lower costs than sponsored research projects at third-party universities. Paul J. Rushton, Ph.D., the company’s vice president of plant biotechnology, will lead...Read More
Joseph Pandolfino has stepped down as chairman and CEO of 22nd Century Group. He will remain a member of the company’s board of directors. According to 22nd Century Group, Pandolfino’s entrepreneurial spirit and vision have enabled the company to create and assemble an important and impressive portfolio of technology, and there are continuing discussions to...Read More
